Alitalo Kari, Carmeliet Peter
Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, Haartman Institute and Helsinki University Central Hospital, POB 63 (Haartmaninkatu 8), 00014 University of Helsinki, Finland.
Cancer Cell. 2002 Apr;1(3):219-27. doi: 10.1016/s1535-6108(02)00051-x.
Studies of the last decades have revealed the importance of angiogenesis for normal growth and for the pathogenesis of numerous diseases. Much less studied is lymphangiogenesis, the growth of lymphatic vessels, which drain extravasated fluid, proteins, and cells and transport them back to the venous circulation. Nonetheless, insufficient lymphangiogenesis causes incapacitating lymphedema, while lymphatic growth around tumors may facilitate metastatic spread of malignant cells that ultimately kill the patient. The recent discovery of the key lymphangiogenic factors VEGF-C and VEGF-D and their receptor VEGFR-3 has allowed novel insights into how the lymphatic vessels and blood vessels coordinately grow and affect human disease. In addition, these studies have opened novel diagnostic and therapeutic avenues for the treatment of lymphedema and metastasis. This overview highlights the recent insights and developments in the field of lymphatic vascular research.
过去几十年的研究揭示了血管生成对于正常生长以及众多疾病发病机制的重要性。相比之下,对淋巴管生成(即淋巴管的生长,淋巴管负责引流外渗的液体、蛋白质和细胞,并将它们输送回静脉循环)的研究要少得多。尽管如此,淋巴管生成不足会导致使人丧失能力的淋巴水肿,而肿瘤周围的淋巴管生长可能会促进恶性细胞的转移扩散,最终导致患者死亡。关键淋巴管生成因子VEGF - C和VEGF - D及其受体VEGFR - 3的最新发现,使人们对淋巴管和血管如何协调生长以及如何影响人类疾病有了新的认识。此外,这些研究为淋巴水肿和转移的治疗开辟了新的诊断和治疗途径。本综述重点介绍了淋巴管研究领域的最新见解和进展。